Crossmark

Reply to: Aspirin use and risk of nonalcoholic fatty liver disease

Crossref DOI link: https://doi.org/10.1007/s10654-025-01253-6

Published Online: 2025-06-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Hangkai

Liu, Zhening

Xu, Chengfu https://orcid.org/0000-0002-6172-1253
License Information

Text and Data Mining valid from 2025-06-14

Version of Record valid from 2025-06-14
More Information

Article History

Received: 15 May 2025

Accepted: 18 May 2025

First Online: 14 June 2025

Declarations

:

: None.

Free to read: This content has been made available to all.